Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 1899087)

Published in PLoS One on July 04, 2007

Authors

Adrienne Anginot1, Romain Dacquin, Marlène Mazzorana, Pierre Jurdic

Author Affiliations

1: Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, Institut Fédératif Biosciences Gerland Lyon Sud, Université Lyon 1, CNRS, INRA, Ecole Normale Supérieure, Lyon, France.

Articles cited by this

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27

RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature (2000) 6.49

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol (2007) 5.86

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med (2006) 5.63

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature (2004) 4.92

Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest (2000) 3.15

The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A (2004) 3.15

Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell (2003) 3.11

Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A (2001) 2.56

B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood (2007) 2.16

IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest (2006) 2.15

PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest (2006) 2.11

DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med (2003) 2.04

Skeletal effects of estrogen. Endocr Rev (1994) 1.91

Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell (2004) 1.91

High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype. J Cell Biochem (2003) 1.87

Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med (2003) 1.80

Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity (2000) 1.77

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A (2003) 1.75

Activating and inhibitory functions of DAP12. Nat Rev Immunol (2007) 1.69

The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res (2003) 1.52

Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci U S A (1997) 1.51

Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest (1994) 1.51

T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res (2006) 1.26

Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology (2000) 1.22

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol (2005) 1.11

Immune responses and bone loss: the estrogen connection. Immunol Rev (2005) 1.02

Arming the osteoclast. Nat Med (2004) 0.99

Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res (2000) 0.99

Use of glass slides coated with apatite-collagen complexes for measurement of osteoclastic resorption activity. J Biomed Mater Res (2000) 0.90

Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis. Am J Physiol Endocrinol Metab (2000) 0.83

Articles by these authors

Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest (2012) 4.31

Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell (2003) 3.11

Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone (2007) 2.33

A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol (2013) 2.04

Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell (2004) 1.91

A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J Cell Sci (2005) 1.87

Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol (2008) 1.59

Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med (2008) 1.54

Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood (2004) 1.50

Paxillin phosphorylation controls invadopodia/podosomes spatiotemporal organization. Mol Biol Cell (2007) 1.39

Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J Cell Biol (2011) 1.32

Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. PLoS One (2008) 1.20

Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol (2002) 1.14

Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J Biol Chem (2003) 1.13

CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol Biol Cell (2007) 1.13

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol (2005) 1.11

IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proc Natl Acad Sci U S A (2004) 1.11

Expression and function of semaphorin 7A in bone cells. Biol Cell (2005) 1.10

Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS One (2010) 1.06

Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood (2008) 1.01

Control of bone resorption by semaphorin 4D is dependent on ovarian function. PLoS One (2011) 1.01

SH3P2 in complex with Cbl and Src. FEBS Lett (2004) 1.00

Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol (2007) 1.00

Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J (2009) 1.00

Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy (2014) 0.96

Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes. Eur J Cell Biol (2002) 0.95

Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. J Bone Miner Res (2010) 0.95

Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin. Endocrinology (2002) 0.93

Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J Immunol (2003) 0.91

Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A. J Virol (2011) 0.91

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation. Differentiation (2009) 0.91

Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A. PLoS One (2013) 0.90

The endoplasmic reticulum is a key component of the plasma cell death pathway. J Immunol (2006) 0.90

Transmigration: a new property of mature multinucleated osteoclasts. J Bone Miner Res (2006) 0.89

Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol (2004) 0.88

Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass. J Bone Miner Res (2011) 0.87

Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice. J Bone Miner Res (2014) 0.87

Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures. Workshop on Invadopodia, Podosomes and Focal Adhesions in Tissue Invasion. EMBO Rep (2008) 0.87

A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Mol Cell Biol (2006) 0.86

An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth. Hum Mol Genet (2012) 0.85

Thyroid hormone T3 acting through the thyroid hormone alpha receptor is necessary for implementation of erythropoiesis in the neonatal spleen environment in the mouse. Development (2005) 0.84

Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts. Mol Biol Cell (2013) 0.84

New insights into adhesion signaling in bone formation. Int Rev Cell Mol Biol (2013) 0.84

Microtubule dynamics differentially regulates Rho and Rac activity and triggers Rho-independent stress fiber formation in macrophage polykaryons. Eur J Cell Biol (2002) 0.84

FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. Biol Cell (2005) 0.84

ERK1 regulates the hematopoietic stem cell niches. PLoS One (2012) 0.82

Podosome rings generate forces that drive saltatory osteoclast migration. Mol Biol Cell (2011) 0.81

CKIP-1 regulates mammalian and zebrafish myoblast fusion. J Cell Sci (2012) 0.81

Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease. Glia (2013) 0.81

Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. J Biol Chem (2014) 0.79

Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. J Hematother Stem Cell Res (2003) 0.78

Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors. FASEB J (2013) 0.77

Odontoblast expression of semaphorin 7A during innervation of human dentin. Matrix Biol (2005) 0.77

Involvement of the orphan nuclear estrogen receptor-related receptor α in osteoclast adhesion and transmigration. J Mol Endocrinol (2010) 0.77

Biphasic Effects of Vitamin D and FGF23 on Human Osteoclast Biology. Calcif Tissue Int (2015) 0.77

p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells. Oncogene (2002) 0.76

[Osteoimmunology: an integrated vision of immune and bone systems]. Med Sci (Paris) (2009) 0.76

DAP12 overexpression induces osteopenia and impaired early hematopoiesis. PLoS One (2013) 0.75

CBP sensitizes v-myb-transformed monoblasts to differentiation inducers. Differentiation (2005) 0.75